LifeVantage operates as a network marketing company
Sita+Acarb, the group treated with metformin placebo, sitagliptin and acarbose
Related: Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds GLP-1 drugs are designed to mimic natural hormones in the body, which suppress appetite and promote weight loss
Engagement within each subscription period was also correlated with a higher likelihood to renew their medication subscription for the next period
Compared with current use (20%) of SGLT2is, widespread use (75%) in the total population with type 2 diabetes was projected to prevent 13,376 non-fatal MIs, 117,240 HF hospitalisations, 6871 ESKD events and 35,989 deaths, but increase the number of non-fatal strokes by 1363 (Table 2)